"This is not who i want to be:" Experiences of opioid-dependent youth before, and during, combined buprenorphine and behavioral treatment

Substance Use and Misuse

Volumn 49, Issue 3, 2014, Pages 303-314

  Moore, Sarah K ^a   Guarino, Honoria ^a   Marsch, Lisa A ^b  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b DARTMOUTH COLLEGE   (United States)

Author keywords

Adolescent; Buprenorphine; Opioid dependent; Qualitative; Treatment; Young adult

Indexed keywords

BUPRENORPHINE; NALOXONE; NARCOTIC ANTAGONIST;

ADOLESCENT; BEHAVIOR THERAPY; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; OPIOID-RELATED DISORDERS; PATIENT ATTITUDE; PSYCHOLOGY; QUALITATIVE RESEARCH; YOUNG ADULT;

ADOLESCENT; BEHAVIOR THERAPY; BUPRENORPHINE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITATIVE RESEARCH; YOUNG ADULT;

EID: 84892169223     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2013.832328     Document Type: Article

References (45)

1. Battjes, R. J., Onken, L. S., & Delaney, P. J. (1999). Drug abuse treatment entry and engagement: Report of a meeting on treatment readiness. Journal of Clinical Psychology, 55(5), 643-657. doi: 10.1002/(SICI) 1097-4679(199905)55:5<643::AID-JCLP11>3.0.CO;2-S
2. Brands, B., Leslie, K., & Catz-Biro, L. (2005). Heroin use and barriers to treatment in street-involved youth. Addiction Research and Theory, 13(5), 477-487. doi: 10.1080/ 16066350500150624
3. Chakrabarti, A., Woody, G. E., Griffin, M. L., Subramaniam, G., & Weiss, R. D. (2010). Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA clinical trials network study. Drug and Alcohol Dependence, 107, 253-256.
4. Chambers, R. A., Taylor, J. R., & Potenza, M. N. (2003). Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. American Journal of Psychiatry, 160(6), 1041-1052.
5. Clemmey, P., Payne, L., & Fishman, M. (2004). Clinical characteristics and treatment outcomes of adolescent heroin users. Journal of Psychoactive Drugs, 36, 85-94. doi:10.1080/ 02791072.2004.10399726
6. Crome, I. B., Christian, J., & Green, C. (1998). Tip of the national iceberg? Profile of adolescent patients prescribed methadone in an innovative community drug service. Drug Education/Prevention Policy, 5, 195-197. doi: 10.3109/ 09687639809006685
7. Eaves, C. S. (2004). Heroin use among female adolescents: The role of partner influence in path of initiation and route of administration. The American Journal of Drug and Alcohol Abuse, 30(1), 21-38. doi: 10.1081/ADA-120029864
8. Fiorentine, R., Nakashima, J., & Anglin, M.D. (1999). Client engagement in drug treatment. The Journal of Substance Abuse Treatment, 17(3), 199-206. PII: S0740-5472(98)00076-2
9. Gandhi, D. H., Kavanagh, G. J., & Jaffe, J. H. (2006). Young heroin users in Baltimore: A qualitative study. The American Journal of Drug and Alcohol Abuse, 32, 177-188. doi: 10.1080/00952990500479290
10. Gordon, S. M. (2002). Surprising data on young heroine users in treatment. Behavioral Healthcare Tomorrow, 11(5), SR30. Retrieved from http://www.ncbi.nlm.nih.gov/ pubmed/12360789.
11. Gordon, S. M., Mulvaney, F., & Rowan, A. (2004). Characteristics of adolescents in residential treatment for heroin dependence. The American Journal of Drug and Alcohol Abuse, 30(3), 593-603. doi: 10.1081/ADA-200032300.
12. Guarino, H. M., Marsch, L. A., Campbell, W. S., Gargano, S., Haller, D. L., & Solhkhah, R. (2009). Methadone maintenance treatment for youth: Experiences of clients, staff and parents. Substance Use and Misuse, 44(14), 1979-1989. doi: 10.3109/ 10826080802494800
13. Herrnstein, R. J. (1970). On the law of effect. Journal of the Experimental Analysis of Behavior, 13(2), 243-266. doi:10.1901/jeab.1970.13-243
14. Hopfer, C. J., Khuri, E., Crowley, T. J., & Hooks, S. (2002). Adolescent heroin use: A review of the descriptive and treatment literature. Journal of Substance Abuse Treatment, 23(3), 231-237. PII: S0740-5472(02)00250-7
15. Hopfer, C. J., Mikulich, S. K., & Crowley, T. J. (2000). Heroin use among adolescents in residential treatment for heroin dependence. American Journal of Drug and Alcohol Abuse, 30(3), 593-603. doi: 10.1081/ADA-200032300)
16. Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2012). Monitoring the future national results on adolescent drug use: Overview of key findings, 2011. Ann Arbor: Institute for Social Research, The University of Michigan. Retrieved from http://www.monitor ingthefuture.org/pubs/ monographs/mtf-overview2011.pdf
17. Jones, E. S., Moore, B. A., Sindelar, J. L., O'Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2009). Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients. Drug and Alcohol Dependence, 99(1-3), 132-140.
18. Lloyd, J. J., Rickets, E. P., Strathdee, S. A., Cornelius, L. J., Bishai, D., Huettner, S., et al. (2005). Social contextual factors associated with entry into opiate agonist treatment among injection drug users. American Journal of Drug and Alcohol Abuse, 31(4), 555-570. doi: 10.1081/ADA-200068114
19. Markus, H., & Nurius, P. (1986). Possible selves. American Psychologist, 41(9), 954-969. doi: 10.1037/0003-066X.41.9.954
20. Marsch, L. A., Bickel, W. K., Badger, G. J., Stothart, M. E., Quesnel, K. J., Stanger, C., et al. (2005). Comparison of pharmacological treatments for opioid dependent adolescents: A randomized, controlled trial. Archives of General Psychiatry, 62, 1157-1164. Retrieved from http:// archpsyc.jamanetwork. com/article.aspx?articleid=209002
21. Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, Jul 8; (3), CD002209. doi: 10.1002/ 14651858.CD002209.pub2.
22. Mattick, R. P., Kimber J., Breen, C., & Davoli, M. (2008). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, Apr 16; (2), CD002207. doi: 10.1002/ 14651858.CD002207.pub3
23. McCabe, S. E., Boyd, C. J., & Teter, C. J. (2005). Illicit use of opioid analgesics by high school seniors. Journal of Substance Abuse Treatment, 28(3), 225-230. doi:10.1016/j.jsat.2004.12. 009
24. Miller, W. R. (1998). Toward a motivational definition and understanding of addiction. TheMotivational Interviewing Newsletter for Trainers, 5(3), 2-6.
25. Motamed, M., Marsch, L. A., Solhkhah, R., Bickel, W. K., & Badger, G. J. (2008). Differences in treatment outcomes between prescription opioid-dependent and heroin-dependent adolescents. Journal of Addiction Medicine, 2(3), 158-164. doi: 10.1097/ ADM.0b013e31816b2f84
26. National Institutes on Drug Abuse (2010). Buprenorphine treatment: A training for multidisciplinary addiction professionals. Retrieved from http://www.attcnetwork.org/explore/priorityareas/science/blendinginitiative/ documents/ TrainersManual.doc.
27. Ozechowski, T. & Liddle, H. A. (2000). Family-based therapy for adolescent drug abuse: Knowns and unknowns. Clinical Child and Family Psychology Review, 3(4), 269-298.
28. Perry, P. D., & Duroy, T. L. H. (2004). Adolescent and young adult heroin and non-heroin users: A quantitative and qualitative study of experiences in a therapeutic community. Journal of Psychoactive Drugs, 36(1), 75-84. doi:10.1080/ 02791072.2004.10399725
29. Premack, D. (1965). Reinforcement theory. In D. Levine (Ed.), Nebraska symposium on motivation (pp. 123-179). Lincoln: University of Nebraska Press.
30. Pugatch, D., Strong, L. L., Has, P., Patterson, D., Combs, C., Reinart, S., et al. (2001). Heroin use in adolescents and young adults admitted for drug detoxification. Journal of Substance Abuse Treatment, 13(3), 337-346. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11693456
31. Rachlin, H. (2000). The lonely addict. InW. Bickel,&R. Vuchinich (Eds.), Reframing health behavior change with behavioral economics (pp. 145-164). Mahwah, New Jersey: Lawrence Erlbaum Associates, Publishers.
32. Roche, A., McCabe, S., & Smyth, B. P. (2008). Illicit methadone use and abuse in young people accessing treatment for opiate dependence. European Addiction Research, 14(4), 219-225. doi:10.1159/000149631
33. Small, W., Fast, D., Krusi, A., Wood, E., & Kerr, T. (2009). Social influences upon injection initiation among street-involved youth in Vancouver, Canada: A qualitative study. Substance Abuse Treatment, Prevention, and Policy, 4(8), doi:10.1186/ 1747-597X-4-8
34. Stotts, A. L., Dodrill, C. L., & Kosten, T. R. (2009). Opioid treatment: Options in pharmacotherapy. Expert Opinion in Pharmacotherapy, 10(11), 1727-1740.
35. Subramaniam, G. A., Fishman, M. J., & Woody, G. (2009). Treatment of opioid-dependent adolescents and young adults with buprenorphine. Current Psychiatry Reports, 11(5), 360-363. doi: 10.1007/s11920-009-0054-5
36. Substance Abuse and Mental Health Services Administration (HHS) (2001). Opioid drugs in maintenance and detoxification treatment of opioid addiction. Final Rule, 21 CFR, Part 291, 42 CFR, Part 8 (January 21, 2001) (Docket No. 98N - 0617, RIN 0910 - AA52). Retrieved from http://www.dpt. samhsa.gov/pdf/regs. pdf.
37. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658.
38. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011. Retrieved from http://www. samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results. htm.
39. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (2010). Treatment Episode Data Set (TEDS). Retrieved from http://wwwdasis. samhsa.gov/webt/NewMapv1.htm.
40. Sung, H. E., Richter, L., Vaughan, R., Johnson, P. B., & Thorn, B. (2005). Non-medical use of prescription opioids among teenagers in the United States: Trends and correlates. Journal of Adolescent Health, 37(1), 44-51. doi:10.1016/j.jadohealth.2005.02.013
41. Volkow, N. D., & Li, T. K. (2004). Drug addiction: The neurobiology of behaviour gone awry. Nature Reviews, 5, 963-970.
42. Vuchinich, R. E., & Tucker, J. (1996). The molar context of alcohol abuse. In L. Green, J. H. Kagel (Eds.), Advances in behavioral economics. Volume 3. Substance use and abuse (pp. 133-162). Norwood, NJ: Ablex.
43. Woody, G. E., Poole, S. A., Subramaniam, G., Dugosh, K, Bogenschutz, M, Abbott, P, et al. (2008). Extended vs shortterm buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial. Journal of the American Medical Association, 300(17):2003-2011. doi: 10.1001/jama.2008.574.
44. Wu, L. T., Ling, W., Burchett, B., Blazer, D. G., Shostak, J., & Woody, G. E. (2010). Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network. Substance Abuse and Rehabilitation, 1, 13-22.
45. Zickler, P. (1999). High-dose methadone improves treatment outcomes. NIDA Notes: Focus on Treatment Research, 14(5). Retrieved from http://archives. drugabuse.gov/NIDA Notes/ NNVol14N5/HighDose.html